Press Releases GSK plc Deutsche Boerse AG

Equities

GS71

GB00BN7SWP63

Market Closed - Deutsche Boerse AG Other stock markets 15:50:00 2024-07-17 EDT			5-day change	1st Jan Change
18.08 ^EUR	+1.86%		+2.49%	+8.40%

07-17	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	MT
07-17	EU court criticizes Commission over handling of COVID vaccine contracts	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK ( '') Transaction notification Form 6 : GSK plc (the 'Company') Transaction notification Form 6 K	07-16	PU
GSK : Transaction notification Form 6 K	07-15	PU
GSK : ViiV Healthcare to announce data from largest head to head randomised clinical trial for 2 drug regimen Dovato against 3 drug regimen Biktarvy at AIDS 2024	07-15	PU
GSK : Q2 2024 pre announcement aide memoire	07-12	PU
Severe Asthma Pipeline 2024 \| Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera	07-12	AQ
Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	07-12	AQ
GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season	07-11	BU
Liver Cancer Pipeline 2024 \| Arcus Biosciences, Yiviva, Virogin Biotech, Tvardi Therapeutics, GlaxoSmithKline, TORL Biotherapeutics, AVEO Pharmaceuticals, Teclison, Epizyme, Sirnaomics	07-10	AQ
Brazil and Thailand become first malaria-endemic countries to launch new single-dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria \| GSK	07-08	AQ
GSK : Brazil and Thailand become first malaria endemic countries to launch new single dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria	07-05	PU
GSK and CureVac to restructure collaboration into new licensing agreement \| GSK	07-04	AQ
GSK : and CureVac to restructure collaboration into new licensing agreement Form 6 K	07-03	PU
GSK plc - Statement, Zantac litigation, Gross case	07-01	AQ
Statement: Zantac (ranitidine) litigation - Gross case \| GSK	07-01	AQ
Statement: Zantac (ranitidine) litigation Gross case Form 6 K	06-28	PU
GSK plc - Statement, US Centers for Disease Control and Prevention's Advisory Committee on Immunisation Practices updates recommendations on adult RSV vaccines ahead of the next season	06-27	AQ
Statement: US Centers for Disease Control and Prevention’s Advisory Committee on Immunisation Practices updates recommendations on adult RSV vaccines ahead of the next season	06-26	PU
GSK's Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis \| GSK	06-25	AQ
Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer \| GSK	06-25	AQ
GSK : Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer Form 6 K	06-24	PU